DrugPatentWatch Database Preview
ANJESO Drug Patent Profile
Email this page to a colleague
Which patents cover Anjeso, and what generic alternatives are available?
Anjeso is a drug marketed by Baudax and is included in one NDA. There are six patents protecting this drug.
This drug has forty-five patent family members in thirteen countries.
The generic ingredient in ANJESO is meloxicam. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anjeso
A generic version of ANJESO was approved as meloxicam by CIPLA on July 19th, 2006.
Summary for ANJESO
| International Patents: | 45 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ANJESO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ANJESO |
| What excipients (inactive ingredients) are in ANJESO? | ANJESO excipients list |
| DailyMed Link: | ANJESO at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ANJESO
US Patents and Regulatory Information for ANJESO
ANJESO is protected by six US patents and one FDA Regulatory Exclusivity.
Patents protecting ANJESO
Nanoparticulate meloxicam formulations
Patent Number: ⤷ Sign up for a Free Trial
Patent Expiration: ⤷ Sign up for a Free Trial
Patented Use: MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION
Nanoparticulate meloxicam formulations
Patent Number: ⤷ Sign up for a Free Trial
Patent Expiration: ⤷ Sign up for a Free Trial
Patented Use: MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION
Patent Number: ⤷ Sign up for a Free Trial
Patent Expiration: ⤷ Sign up for a Free Trial
Patented Use: MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION
Method of treating pain in elderly patients with mild renal impairment
Patent Number: ⤷ Sign up for a Free Trial
Patent Expiration: ⤷ Sign up for a Free Trial
Patented Use: MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION IN PATIENTS WITH MILD RENAL IMPAIRMENT
Nanoparticulate meloxicam formulations
Patent Number: ⤷ Sign up for a Free Trial
Patent Expiration: ⤷ Sign up for a Free Trial
Patented Use: MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INTRAVENOUS INJECTION
Reduction of flake-like aggregation in nanoparticulate active agent compositions
Patent Number: ⤷ Sign up for a Free Trial
Patent Expiration: ⤷ Sign up for a Free Trial
FDA Regulatory Exclusivity protecting ANJESO
NEW PRODUCT
Exclusivity Expiration: ⤷ Sign up for a Free Trial
International Patents for ANJESO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1617816 | ⤷ Sign up for a Free Trial |
| Spain | 2701673 | ⤷ Sign up for a Free Trial |
| Spain | 2609415 | ⤷ Sign up for a Free Trial |
| Australia | 2019364416 | ⤷ Sign up for a Free Trial |
| European Patent Office | 3167875 | ⤷ Sign up for a Free Trial |
| China | 111201020 | ⤷ Sign up for a Free Trial |
| Japan | 2021527697 | ⤷ Sign up for a Free Trial |
| >Country | >Patent Number | >Estimated Expiration |
